The availability of data, experts for authoring abstracts, posters and oral presentations, and congress activities themselves have all been affected by the pandemic.
Category: Publications
Effective congress planning for publications teams
Assessing and managing issues around clinical trials: a multi-stakeholder approach
Many companies are facing challenging decisions on whether to proceed with clinical trials in the coming months as countries experience varying degrees of lockdown.
Publications planning post-pandemic
Clearly the delay/postponement/cancellation of clinical trials owing to the COVID-19 pandemic will have an impact on the availability of data to communicate, but this is not the only way in which the pandemic is reshaping the publications landscape.
Unlocking virtual medical congresses
Medical congresses – crucial for the presentation of trial data, scientific exchange and the opportunity to engage with medical professionals, patient advocates, media and analysts – have been cancelled, postponed or are moving to virtual/part virtual.